Nikolaos A. Trikalinos, MD

Nikolaos A. Trikalinos, MD

Associate Professor

Address:
Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110
11th Floor, Mid Campus Center (office)

Admin:
Lisa Forbush
forbushla@wustl.edu 

Clinical Interests
Research Interests
  • Neuroendocrine tumors
Research

We are exclusively focused on patients with neuroendocrine neoplasms. We are currently working on identifying the causes of tumorigenesis and developing new strategies to cure both high and low grade disease. To that end, we are very interested in raising awareness, promoting patient engagement and research support.

Profiles (publications)
WU Physician Bio

Biosketch

Education

  • 2019-2016: MS in Regulatory Science, John Hopkins University, Baltimore, MD
  • 2015-2014: Science of Clinical Investigation Certificate, John Hopkins University, Baltimore, MD
  • 2007-2001: Research Associate, Department of Biochemistry, University of Ioannina Medical School, Ioannina, Greece
  • 2005-1999: MD, University of Ioannina Medical School, Ioannina, Greece

Academic Positions & Employment

  • present-2023: Associate Professor, Department of Medicine, Washington University, St. Louis, MO
  • 2023-2017: Assistant Professor, Department of Medicine, Washington University, St. Louis, MO
  • 2017-2014: US Oncology, Maryland Oncology/Hematology Associates
  • 2014-2011: Hematology/Oncology Fellow, Greenebaum Cancer Center, University of Maryland Medical Center, Baltimore, MD
  • 2011-2010: Chief resident in Internal Medicine, MetroWest Medical Center, Framingham, MA
  • 2010-2007: Resident in Internal Medicine, MetroWest Medical Center, Framingham, MA
  • 2007-2005: Research Associate, Department of Clinical Epidemiology, University of Ioannina Medical School, Greece

University & Hospital Appointments & Committees

  • present-2019: Committee on Admissions, Washington University
  • present-2019: NANETS Communications Committee (currently Co-Chair)
  • present-2018: NCCN Panel, Neuroendocrine Tumors
  • present-2018: Organizer and Moderator, Neuroendocrine Tumor Board, Washington University
  • present-2018: Patient Safety Officer for Inpatient Oncology, Washington University
  • present-2018: Operations Executive Committee, Washington University
  • present-2017: OutMed Advisory Board, Washington University
  • present-2017: Protocol Review Committee, Washington University
  • 2017-2014: Research Committee, US Oncology Network/Maryland Oncology-Hematology
  • 2011-2010: Co-Chairman, Physician Nurse Collaboration Council, MetroWest Medical Center
  • 2011-2010: Graduate Medical Education Committee, MetroWest Medical Center
  • 2011-2010: Ethics Committee, MetroWest Medical Center

Board Certification

  • 2014: American Board of Internal Medicine, Hematology
  • 2014: American Board of Internal Medicine, Oncology
  • 2010: American Board of Internal Medicine

Honors & Awards

  • 2015: US Oncology Network Excellence in Research Award, Co-recipient, Maryland Oncology/Hematology Branch
  • 2014: Research Award, Class of 2014, University of Maryland Greenebaum Cancer Center
  • 2011: Outstanding Performance Award, Chief Residency Position, Metrowest Medical Center
  • 2011: Compliance Award, Outstanding Documentation, Hematology/Oncology Fellowship Program, University of Maryland
  • 1999: Greek Chemistry Competition, 4th place – selection for World Chemistry Olympiad, Thailand

Professional Societies

  • present-2019: Alliance for Clinical Trials in Oncology, Immuno-oncology Committee
  • present-2017: North American Neuroendocrine Tumor Society
  • present-2015: Society of Neuro-Oncology
  • present-2011: American Society of Clinical Oncology
  • 2014-2012: American Society of Hematology
  • 2010-2009: Massachusetts Medical Society
  • 2009-2007: American College of Physicians, Associate